Inaxaplin Reduces Proteinuria in Additional APOL1 Kidney Disease Populations
Vertex reported Phase 2b AMPLIFIED data in 41 people with APOL1 mediated kidney disease. Inaxaplin 45 mg once daily on top of standard care reduced urine albumin to creatinine ratio by 42.7 percent at…
